Manners J M, Walters F J
Anaesthesia. 1979 Jan;34(1):3-9. doi: 10.1111/j.1365-2044.1979.tb04859.x.
Twenty-six patients with severe coronary artery disease, receiving long term beta-adrenoceptor blocking drugs were anaesthetised for aorto-coronary bypass operations. Beta-adrenoceptor blocking drugs were withdrawn 2 to 8 days before surgery in ten patients only. In the remaining sixteen patients there were no serious complications due to the presence of a degree of beta-blockade during anaesthesia and surgery. The undesirable cardiovascular responses to laryngoscopy and tracheal intubation were diminished in these patients, and the rise in heart rate/systolic pressure product, and indicator of myocardial oxygen consumption, was less in this group. The need for peripheral vasodilators to treat systemic arterial pressure rises in response to surgery was also reduced. There appeared to be no contraindication to the continuation of beta-adrenoceptor blockade before operation in patients undergoing aorto-coronary bypass procedures when suitable anaesthetic agents were selected and when an appropriate blood volume was maintained.
26例患有严重冠状动脉疾病且长期服用β-肾上腺素能受体阻滞剂的患者接受了主动脉冠状动脉搭桥手术麻醉。仅10例患者在手术前2至8天停用β-肾上腺素能受体阻滞剂。其余16例患者在麻醉和手术期间由于存在一定程度的β受体阻滞而未出现严重并发症。这些患者对喉镜检查和气管插管的不良心血管反应有所减轻,且该组中心率/收缩压乘积(心肌氧耗指标)的升高幅度较小。用于治疗因手术导致的体循环动脉压升高的外周血管扩张剂的需求也减少了。当选择合适的麻醉剂并维持适当血容量时,对于接受主动脉冠状动脉搭桥手术的患者,术前继续使用β-肾上腺素能受体阻滞剂似乎并无禁忌。